Application of propranolol in ocular hemangioma of infant

International Journal of Ophthalmology

Volumn 12, Issue 1, 2012, Pages 157-158

  Xiong, Shi ^a   Luo, Jun ^a   Zhou, Li Jun ^a   Wang, Xi Lang ^a   Tao, Li Juan ^a   Yang, Hui Ling ^a  

^a HUNAN CHILDREN'S HOSPITAL   (China)

Author keywords

Hemangioma; Propranolol

Indexed keywords

PREDNISONE ACETATE; PROPRANOLOL;

ARTICLE; CONTROLLED STUDY; EYELID DISEASE; HEMANGIOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY;

EID: 84860813744     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-5123.2012.01.52     Document Type: Article

References (6)

1. Takahashi K, Mulliken J B, Kozakewich H P, et al. Celluar markers that distinguish the phase of hemangioma during infancy and childhood. J Clin Invest 1994; 93(6): 2357-2364
2. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358(24): 2649-2651
3. 2005; 40(3): 185-186
4. 2009: 2(5): 275
5. Frieden I J, Eichenfield L F, Esteriy N B, et al. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997; 37(4): 631-637
6. O'Keefe M, Lanigan B, Byrne S A. Capillary hacmangioma of the eyelids and orbit: a clinical review of the safety and efficacy of intralesional steroid. Acta Ophthalmol Scand 2003; 81(3): 294